Drug Resistance: Research: Overviews
- Transmitted Antiretroviral Drug Resistance Hold Steady at 16% (Video) (March 25, 2013)
From HIVandHepatitis.com
- California: Studying Drug-Resistant HIV in Los Angeles County (March 19, 2013)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- Eradication/Cure, Prevention, Novel Strategies for Administration of PrEP (Delivery Alternatives), Antiretroviral Therapy/Drug Resistance/New Drugs/Comorbidities (March 17, 2013)
From National AIDS Treatment Advocacy Project
- Resistance to Darunavir Falling Since Approval of the Protease Inhibitor in 2006 (March 11, 2013)
From National AIDS Treatment Advocacy Project
- Can People With Resistant HIV Omit NRTIs When Switching From a Failing Regimen? (March 7, 2013)
From aidsmap.com
- Can People With Resistant HIV Omit NRTIs When Switching to a New Regimen? (Video) (March 7, 2013)
From HIVandHepatitis.com
- Wide U.S. Study Finds 16% With Newly Diagnosed HIV Carry Resistant Virus (March 6, 2013)
From National AIDS Treatment Advocacy Project
- Transmission of Resistant HIV Steady (March 6, 2013)
From MedPage Today
- Dolutegravir: Integrase Resistance and the Impact of the Background Regimen (November/December 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Resistance in Infants and Children Receiving ART in South Africa (November/December 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
 Mathematical Model Helps Design Efficient Multi-Drug Therapies (September 10, 2012)
In Positively Aware, from Test Positive Aware Network
On TheBodyPRO.com
- Drug Resistance Increasing in Parts of Africa, Report Shows (July 24, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- ARV Drug Resistance Levels Steady in Low-, Middle-Income Countries, WHO Report Says (July 19, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
- Children With HIV in Asia Suffer Resistance to AIDS Drugs (December 8, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- Big Falls in Prevalence of Protease Inhibitor and Triple-Class Resistance (September 19, 2011)
From aidsmap.com
- "Smart Bomb" RNA Molecule Could Take Out Drug-Resistant HIV (February 2, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- Four-Drug Combination Has High Success Rate in HIVers With Multidrug Resistance (October 19, 2009)
From aidsmap.com
- Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms (August 1, 2009)
In The Journal of Infectious Diseases
- Nucleoside RT Inhibitor Surveillance Drug Resistance Mutation (SDRM) List: 34 Mutations at 15 Positions (March 6, 2009)
In PLoS ONE
- Natural Variation of HIV-1 Group M Integrase: Implications for a New Class of Antiretroviral Inhibitors (August 7, 2008)
In Retrovirology
- News on HIV Drug Resistance in New Antiretrovirals From the XVI International HIV Drug Resistance Workshop (July 24, 2007)
With every new medication it's critical to understand which mutations are predictive of a less than optimal response. In this report on Doug Richman's review from the XVI International HIV Drug Resistance Workshop, Mark Holodniy, M.D., discusses genotypic and phenotypic assays associated with R5 inhibitors and HIV drug resistance associated with the following antiretrovirals in development: etravirine, raltegravir, elvitegravir and maraviroc.
In 4th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
|
Advertisement
|
Email
Glossary
